Max India Limited Appoints Former McKinsey Senior Partner Mrinalini Mirchandani as Independent Director
Max India Limited's Board of Directors approved the appointment of Ms. Mrinalini Mirchandani as Additional Independent Director for a five-year term from April 15, 2026 to April 14, 2031. Ms. Mirchandani, a former Senior Partner at McKinsey & Company and the first woman to hold this position in the firm's 34-year India history, brings extensive experience in private equity, healthcare, and strategic consulting. The appointment, subject to shareholder approval, complies with SEBI listing regulations.

*this image is generated using AI for illustrative purposes only.
Max India Limited has announced the appointment of Ms. Mrinalini Mirchandani as Additional Director in the capacity of Independent Director. The Board of Directors approved this appointment on April 9, 2026 via circular resolution, following the recommendation of the Nomination and Remuneration Committee.
Appointment Details
The appointment encompasses a five-year term commencing on April 15, 2026 and concluding on April 14, 2031. The decision is subject to approval from shareholders and has been disclosed in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Parameter: | Details |
|---|---|
| Director Name: | Ms. Mrinalini Mirchandani |
| DIN: | 11619010 |
| Position: | Additional Director (Independent Director) |
| Term Duration: | 5 years |
| Commencement Date: | April 15, 2026 |
| End Date: | April 14, 2031 |
| Approval Status: | Subject to shareholder approval |
Professional Background
Ms. Mirchandani brings distinguished experience from her tenure at McKinsey & Company, where she served as Senior Partner. She holds the distinction of being the first and only woman elected to the Senior Partner position in McKinsey's 34-year history in India.
At McKinsey, she led the Private Equity Practice in India and served as a member of the global healthcare leadership team. Her responsibilities also included overseeing the Organization & Talent practice in India. Prior to McKinsey, she worked at Merrill Lynch, leading their Healthcare & Consumer Investment Banking Team in India, and headed the Healthcare recruiting practice for Egon Zehnder in India.
Educational Qualifications and Recognition
Ms. Mirchandani holds an MBA from IIM Calcutta and a B.Com from Mumbai University. Her professional achievements were recognized in 2018 when she was featured in the Economic Times list of India's 40 under Forty Young Business Leaders.
Regulatory Compliance
The company has confirmed that Ms. Mirchandani is not related to any other Director of the Company and is not debarred from holding the office of Director by virtue of any order passed by SEBI or any other authority. The appointment disclosure complies with all requirements under SEBI listing regulations and relevant circulars.
Over the past two decades, Ms. Mirchandani has collaborated with leading Indian and global institutions on various strategic initiatives including growth strategy, mergers and acquisitions, capital raising, talent management, and delivering transformational change at scale.
Historical Stock Returns for Max India
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.99% | +7.46% | +7.98% | -26.50% | -9.35% | +149.12% |
What strategic initiatives or transformation plans might Max India be considering that would benefit from Ms. Mirchandani's private equity and healthcare expertise?
How could Ms. Mirchandani's M&A experience at McKinsey influence Max India's potential acquisition or divestiture strategies in the coming years?
Will Max India's board composition changes signal a shift toward more healthcare-focused investments or operational improvements?


































